Skip to main content

Table 1 The characteristics of enrolled patients

From: Elobixibat alleviates chronic constipation in hemodialysis patients: a questionnaire-based study

VariableMean ± SD and Median [IQR]
Number of enrolled patients27
Sex (Male/Female)18/9
Etiology of end-stage renal diseaseDiabetic nephropathy, 12 patients
Nephrosclerosis, 6 patients
CGN, 6 patients
ADPKD, 2 patients
Graft loss, 1 patient
Age (year)70 ± 13, 75 [57, 80]
Dialysis duration (year)8 ± 9, 6 [1,11]
Dry weight (kg)58.1 ± 13.3, 58.1 [53.7, 61.5]
Single pool Kt/V1.08 ± 0.25, 1.11 [0.86, 1.30]
Concomitant laxative1 type drug: 13 patients
2 types drugs: 10 patients
3 types drugs: 4 patients
Type of concomitant laxativeSennosides A and B, 26 patients
Sodium picosulfate hydrate, 5 patients
Glycerine enema, 1 patient
Lactulose, 2 patients
Sodium dihydrogen phosphate/sodium hydrogen carbonate, 2 patients
Lubiprostone, 5 patients
Lactomin, 3 patients
Daikenchuto, 1 patient
Phosphate binder0 drug, 3 patients
1 type of drug, 15 patients
2 types of drug, 9 patients
Type of phosphate binderLantern carbonate, 6 patients
Calcium carbonate, 19 patients
Ferric citrate, 6 patients
Sucroferric oxyhydroxide, 2 patients
  1. CGN chronic glomerulonephritis, ADPKD autosomal dominant polycystic kidney disease